PVT1 and lung cancer: Our study is the first to combine PVT1 and miR-143–3p within a ceRNA axis that converges on CDK1, offering a systems-level viewpoint that unifies non-coding RNA regulation with a central cell cycle kinase, even though both have been previously connected to lung cancer.